Lawrence Steinman - Director at Pasithea Therapeutics Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
KTTA, KTTAW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Lawrence Steinman - trading volume in the past year for Pasithea Therapeutics Corp.

Holdings reported by Lawrence Steinman for Pasithea Therapeutics Corp.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 200K $150K $0.75 Nov 28, 2025 Direct
Stock Option (right to buy) 243K Oct 24, 2025 Direct Common Stock

Transactions reported by Lawrence Steinman for Pasithea Therapeutics Corp.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.